, Volume 49, Issue 7, pp 541–544 | Cite as

Reversible focal splenial lesions

  • Massimo GallucciEmail author
  • Nicola Limbucci
  • Amalia Paonessa
  • Ferdinando Caranci
Invited Review


Reversible focal lesions in the splenium of the corpus callosum (SCC) have recently been reported.They are circumscribed and located in the median aspect of the SCC. On MRI, they are hyperintense on T2-W and iso-hypointense on T1-W sequences, with no contrast enhancement. On DWI, SCC lesions are hyperintense with low ADC values, reflecting restricted diffusion due to cytotoxic edema. The common element is the disappearance of imaging abnormalities with time, including normalization of DWI. Clinical improvement is often reported. The most established and frequent causes of reversible focal lesions of the SCC are viral encephalitis, antiepileptic drug toxicity/withdrawal and hypoglycemic encephalopathy. Many other causes have been reported, including traumatic axonal injury. The similar clinical and imaging features suggest a common mechanism induced by different pathological events leading to the same results. Edema and diffusion restriction in focal reversible lesions of the SCC have been attributed to excitotoxic mechanisms that can result from different mechanisms; no unifying relationship has been found to explain all the pathologies associated with SCC lesions. In our opinion, the similar imaging, clinical and prognostic aspects of these lesions depend on a high vulnerability of the SCC to excitotoxic edema and are less dependent on the underlying pathology. In this review, the relevant literature concerning reversible focal lesions in the SCC is analyzed and hypotheses about their pathogenesis are proposed.


CNS Corpus callosum Toxic diseases Metabolic diseases 



  1. 1.
    Oster J, Doherty C, Grant PE, Simon M, Cole AJ (2003) Diffusion-weighted imaging abnormalities in the splenium after seizures. Epilepsia 44:852–854PubMedCrossRefGoogle Scholar
  2. 2.
    Cohen-Gadol AA, Britton JW, Jack CR, Friedman JA, Marsh WR (2002) Transient postictal magnetic resonance imaging abnormality of the corpus callosum in a patient with epilepsy. J Neurosurg 97:714–717PubMedCrossRefGoogle Scholar
  3. 3.
    Mirsattari SM, Lee DH, Jones MW, Blume WT (2003) Transient lesion in the splenium of the corpus callosum in an epileptic patient. Neurology 60:1838–1841PubMedGoogle Scholar
  4. 4.
    Kim SS, Chang KH, Kim ST, Suh DC, Cheon JE, Jeong SW, Han MH, Lee SK (1999) Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol 20:125–129PubMedGoogle Scholar
  5. 5.
    Polster T, Hoppe M, Ebner A (2001) Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry 70:459–463PubMedCrossRefGoogle Scholar
  6. 6.
    Gurtler S, Ebner A, Tuxhorn I, Ollech I, Pohlmann-Eden B, Woermann FG (2005) Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal. Neurology 65:1032–1036PubMedCrossRefGoogle Scholar
  7. 7.
    Tada H, Takanashi J, Barkovich AJ, Oba H, Maeda M, Tsukahara H, Suzuki M, Yamamoto T, Shimono T, Ichiyama T, Taoka T, Sohma O, Yoshikawa H, Kohno Y (2004) Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 63:1854–1858PubMedGoogle Scholar
  8. 8.
    Hagemann G, Mentzel HJ, Weisser H, Kunze A, Terborg C (2006) Multiple reversible MR signal changes caused by Epstein-Barr virus encephalitis. AJNR Am J Neuroradiol 27:1447–1449PubMedGoogle Scholar
  9. 9.
    Takanashi J, Barkovich AJ, Shiihara T, Tada H, Kawatani M, Tsukahara H, Kikuchi M, Maeda M (2006) Widening spectrum of a reversible splenial lesion with transiently reduced diffusion. AJNR Am J Neuroradiol 27:836–838PubMedGoogle Scholar
  10. 10.
    Bulakbasi N, Kocaoglu M, Tayfun C, Ucoz T (2006) Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis/encephalopathy. AJNR Am J Neuroradiol 27:1983–1986PubMedGoogle Scholar
  11. 11.
    Doherty MJ, Jayadev S, Watson NF, Konchada RS, Hallam DK (2005) Clinical implications of splenium magnetic resonance imaging signal changes. Arch Neurol 62:433–437PubMedCrossRefGoogle Scholar
  12. 12.
    Bottcher J, Kunze A, Kurrat C, Schmidt P, Hagemann G, Witte OW, Kaiser WA (2005) Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis. Stroke 36:e20–e22PubMedCrossRefGoogle Scholar
  13. 13.
    Lo L, Tan CHA, Umapathi T, Lim CC (2006) Diffusion-weighted MR imaging in early diagnosis and prognosis of hypoglycemia. AJNR Am J Neuroradiol 27:1222–1224PubMedGoogle Scholar
  14. 14.
    Loh Y, Watson WD, Verma A, Krapiva P (2003) Restricted diffusion of the splenium in acute Wernicke’s encephalopathy. J Neuroimaging 15:373–375CrossRefGoogle Scholar
  15. 15.
    Gass A, Birtsch C, Oster M, Schwartz A, Hennerici MG (1998) Marchiafava-Bignami disease: reversibility of neuroimaging abnormality. J Comput Assist Tomogr 22:503–504PubMedCrossRefGoogle Scholar
  16. 16.
    Winslow H, Mickey B, Frohman EM (2006) Sympathomimetic-induced kaleidoscopic visual illusion associated with a reversible splenium lesion. Arch Neurol 63:135–137PubMedCrossRefGoogle Scholar
  17. 17.
    Ogura H, Takaoka M, Kishi M, Kimoto M, Shimazu T, Yoshioka T, Sugimoto H (1998) Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy. AJNR Am J Neuroradiol 19:1144–1145PubMedGoogle Scholar
  18. 18.
    Wong SH, Turner N, Birchall D, Walls TJ, English P, Schmid ML (2004) Reversible abnormalities of DWI in high-altitude cerebral oedema. Neurology 62:335–336PubMedGoogle Scholar
  19. 19.
    Takayama H, Kobayashi M, Sugishita M, Mihara B (2000) Diffusion-weighted imaging demonstrates transient cytotoxic oedema involving the corpus callosum in a patient with diffuse brain injury. Clin Neurol Neurosurg 102:135–139PubMedCrossRefGoogle Scholar
  20. 20.
    Albayram S, Ozer H, Gokdemir S, Gulsen F, Kiziltan G, Kocer N, Islak C (2006) Reversible reduction of apparent diffusion coefficient values in bilateral internal capsules in transient hypoglycemia-induced hemiparesis. AJNR Am J Neuroradiol 27:1760–1762PubMedGoogle Scholar
  21. 21.
    Kizilkilic O, Karaca S (2004) Influenza-associated encephalitis-encephalopathy with a reversible lesion in the splenium of the corpus callosum: case report and literature review. AJNR Am J Neuroradiol 25:1863–1864PubMedGoogle Scholar
  22. 22.
    Takanashi J, Barkovich AJ, Yamaguchi K, Kohno Y (2004) Influenza encephalopathy with a reversible lesion in the splenium of the corpus callosum. AJNR Am J Neuroradiol 25:798–802PubMedGoogle Scholar
  23. 23.
    Takanashi J, Hirasawa K, Tada H (2006) Reversible restricted diffusion of the entire corpus callosum. J Neurol Sci 247:101–104PubMedCrossRefGoogle Scholar
  24. 24.
    Moritani T, Smoker WRK, Sato Y, Numaguchi Y, Westesson PLA (2005) Diffusion-weighted imaging of acute excitotoxic brain injury. AJNR Am J Neuroradiol 26:216–228PubMedGoogle Scholar
  25. 25.
    Werner P, Pitt D, Raine CS (2001) Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50:169–180PubMedCrossRefGoogle Scholar
  26. 26.
    Takanashi J, Maeda M, Hayashi M (2005) A neonate showing a reversible splenial lesion. Arch Neurol 62:1481–1482PubMedCrossRefGoogle Scholar
  27. 27.
    Roychowdhury S, Maldjan JA, Grossman RI (2000) Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. AJNR Am J Neuroradiol 21:869–874PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Massimo Gallucci
    • 1
    Email author
  • Nicola Limbucci
    • 1
  • Amalia Paonessa
    • 2
  • Ferdinando Caranci
    • 3
  1. 1.Department of Radiology, S. Salvatore HospitalUniversity of L’AquilaL’AquilaItaly
  2. 2.Department of NeuroradiologyLoreto Nuovo HospitalNapoliItaly
  3. 3.Neuroradiology, Department of Neurological SciencesFederico II UniversityNapoliItaly

Personalised recommendations